The investment seeks capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
UTMAX | 12.03 | N/A | N/A |
Victory Target Managed Allocation | |||
FPHAX | 28.62 | N/A | N/A |
Fidelity Select Pharmaceuticals Port | |||
GSILX | 21.81 | N/A | N/A |
Goldman Sachs GQG Ptnrs Intl Opps C | |||
HLIDX | 15.65 | N/A | N/A |
Harding Loevner Intl Dev Mkts Eq Inst | |||
DLCZX | 12.27 | -0.06 | -0.49% |
Destinations Large Cap Equity Z |
A.I.dvisor indicates that over the last year, IBSSX has been closely correlated with PEMGX. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBSSX jumps, then PEMGX could also see price increases.
Ticker / NAME | Correlation To IBSSX | 1D Price Change % | ||
---|---|---|---|---|
IBSSX | 100% | N/A | ||
PEMGX - IBSSX | 86% Closely correlated | N/A | ||
FSMAX - IBSSX | 83% Closely correlated | N/A | ||
JDMAX - IBSSX | 70% Closely correlated | N/A | ||
JDMRX - IBSSX | 68% Closely correlated | N/A | ||
RPTIX - IBSSX | 65% Loosely correlated | N/A | ||
More |